Replies to post #33 on TRACON Pharmaceuticals Inc (TCON)

[DewDiligence]

It’s an event-driven trial where PFS is the primary endpoint; clinicaltrials.gov shows Sep 2018 as the estimated date for the primary analysis:

https://www.clinicaltrials.gov/ct2/show/NCT02979899

p.s. Pazopanib = Votrient (a GSK drug).